British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
GSK's specialty medicines segment showed strong performance, growing over 20% due to successful new launches. Additionally, GSK is currently undervalued, trading at £16.1, significantly below the ...
The company's strategic focus on innovation, particularly in R&D, is evident from its investments in new vaccines and medicines, combining scientific focus on the immune system with advanced ...
(RTTNews) - Drug maker GSK plc (GSK, GSK.L ... Labour and Welfare or MHLW has accepted for review a new drug application (NDA) for Blenrep in combination with bortezomib plus dexamethasone ...
Miels said the new plan includes “changing our marketing mix to focus on segments who are tougher to activate.” Making Shields part of the marketing mix has enabled GSK to win mainstream media ...
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares opened today at p1,644. ...
This summer, GSK cut its yearly vaccine sales projection ... With sales of its flagship shingles vaccine Shingrix separately faltering, new data on co-administration of the two adult vaccines ...
GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...
The new vaccine is a combination of GSK’s already-approved vaccines Bexsero and Menveo and is designed to protect against meningitis and blood poisoning caused by the A, B, C, W, and Y ...
By Stephen Merelman Tren de Aragua’s emergence in New York City and elsewhere has led law enforcement officials to strategize how to stem the gang’s growth. By Luis Ferré-Sadurní and ...